Literature DB >> 2404447

Identification of adverse events occurring during hospitalization. A cross-sectional study of litigation, quality assurance, and medical records at two teaching hospitals.

T A Brennan1, A R Localio, L L Leape, N M Laird, L Peterson, H H Hiatt, B A Barnes.   

Abstract

STUDY
OBJECTIVES: To estimate the efficacy of a medical record review for identifying adverse events and negligent case suffered by hospitalized patients.
DESIGN: Cross-sectional study comparing an objective medical record review with information available from hospital quality assurance records as well as risk management and litigation records.
SETTING: Two metropolitan teaching hospitals in the northeastern United States.
MEASUREMENTS AND MAIN RESULTS: Using the litigation and risk management records as a criterion standard, we found that the medical record review had a sensitivity of 80% (93 of 116; 95% CI, 73% to 88%) for discovering adverse events and a sensitivity of 76% (51 of 67; 95% CI, 66% to 86%) for discovering negligent care. We estimated that record review of a random sample of hospitalizations across a geographic region would have even higher sensitivity (adverse-event sensitivity, 84%; negligence sensitivity, 80%). Moreover, we found that the adverse events we failed to discover led to less costly malpractice claims. A significant number of adverse events (20 of 172) among hospitalizations never gave rise to litigation or risk management investigation. Six of the twenty were due to negligent care. Quality assurance efforts at the level of the clinical departments in one hospital led to review of only 12 out of 82 risk management records.
CONCLUSIONS: The overwhelming majority of adverse events and episodes of negligent care are discoverable with the methods we used to evaluate medical records. Quality assurance efforts using similar record review methods should be further evaluated.

Entities:  

Mesh:

Year:  1990        PMID: 2404447     DOI: 10.7326/0003-4819-112-3-221

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  32 in total

1.  A look into the nature and causes of human errors in the intensive care unit. 1995.

Authors:  Y Donchin; D Gopher; M Olin; Y Badihi; M Biesky; C L Sprung; R Pizov; S Cotev
Journal:  Qual Saf Health Care       Date:  2003-04

Review 2.  Detecting adverse events using information technology.

Authors:  David W Bates; R Scott Evans; Harvey Murff; Peter D Stetson; Lisa Pizziferri; George Hripcsak
Journal:  J Am Med Inform Assoc       Date:  2003 Mar-Apr       Impact factor: 4.497

3.  Electronic health records and adverse drug events after patient transfer.

Authors:  K S Boockvar; E E Livote; N Goldstein; J R Nebeker; A Siu; T Fried
Journal:  Qual Saf Health Care       Date:  2010-08-19

4.  Automated detection of adverse events using natural language processing of discharge summaries.

Authors:  Genevieve B Melton; George Hripcsak
Journal:  J Am Med Inform Assoc       Date:  2005-03-31       Impact factor: 4.497

Review 5.  Disclosure of adverse events and errors in surgical care: challenges and strategies for improvement.

Authors:  Lauren E Lipira; Thomas H Gallagher
Journal:  World J Surg       Date:  2014-07       Impact factor: 3.352

6.  Use of morning report to enhance adverse event detection.

Authors:  C H Welsh; R Pedot; R J Anderson
Journal:  J Gen Intern Med       Date:  1996-08       Impact factor: 5.128

7.  Occurrence screening as a method of audit.

Authors:  J Bennett; K Walshe
Journal:  BMJ       Date:  1990-05-12

8.  Prescribing discrepancies likely to cause adverse drug events after patient transfer.

Authors:  K S Boockvar; S Liu; N Goldstein; J Nebeker; A Siu; T Fried
Journal:  Qual Saf Health Care       Date:  2009-02

9.  Health and life insurance as an alternative to malpractice tort law.

Authors:  Walton Sumner
Journal:  BMC Health Serv Res       Date:  2010-06-02       Impact factor: 2.655

10.  Impact of procedure-related complications on patient outcome on a general medicine service.

Authors:  M D Nettleman; M J Bock; A P Nelson; J Fieselmann
Journal:  J Gen Intern Med       Date:  1994-02       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.